Diabetes mellitus, HIV infection, and vitamin D: Time to act or time to think?

AIDS

Volumn 25, Issue 4, 2011, Pages 531-533

  Gharakhanian, Shahin ^a   Kotler, Donald P ^b  

^a VERTEX PHARMACEUTICALS   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; COLECALCIFEROL; ERGOCALCIFEROL; TOLL LIKE RECEPTOR 7; VITAMIN D; VITAMIN D RECEPTOR;

ANTIVIRAL THERAPY; BODY MASS; BONE MINERALIZATION; EDITORIAL; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INNATE IMMUNITY; INSULIN RESISTANCE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TH1 CELL; TH17 CELL; VIRUS REPLICATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

DIABETES MELLITUS, TYPE 2; HIV INFECTIONS; HUMANS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 79951472097     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283434734     Document Type: Editorial

References (28)

1. Friedman PA. Agents affecting mineral ion homeostasis and bone turnover. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gilman's, the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill; 2006. pp. 1647-1678.
2. Norman AW, Bouillon R. Vitamin D nutritional policy needs a vision for the future. Exp Biol Med 2010; 235:1034-1045.
3. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311:1770-1773.
4. Tang J, Zhou R, Luger D, Zhu W, Silver PB, Grajewski RS, et al. Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J Immunol 2009; 182:4624-4632.
5. Szep Z, Guaraldi G, Shah S, LoRe V, Ratcliffe SJ, Orlando G, et al. Vitamin D deficiency is associated with type 2 diabetes mellitus in HIV infection. AIDS 2010; 25:525-529.
6. Skolnik PR, Jahn B, Wang MZ, Rota TR, Hirsch MS, Krane SM. Enhancement of human immunodeficiency virus 1 replication in monocytes by 1,25- dihydroxycholecalciferol. Proc Natl Acad Sci USA 1991; 88:6632-6636. (Pubitemid 21915003)
7. Pauza CD, Kornbluth R, Emau P, Richman DD, Deftos LJ. Vitamin D3 compounds regulate human immunodeficiency virus type 1 replication in U937 monoblastoid cells and in monocyte-derived macrophages. J Leukoc Biol 1993; 53:157-164. (Pubitemid 23100158)
8. Biswas P, Mengozzi M, Mantelli B, Delfanti F, Brambilla A, Vicenzi E, Poli G. 1,25-Dihydroxyvitamin D3 upregulates functional CXCR4 human immunodeficiency virus type 1 cor-eceptors in U937 minus clones: NF- kappaB-independent enhancement of viral replication. J Virol 1998; 72:8380-8383. (Pubitemid 28421843)
9. Nevado J, Tenbaum SP, Castillo AI, Sanchez-Pacheco A, Aranda A. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3. J Mol Endocrinol 2007; 38:587-601. (Pubitemid 47019061)
10. Haug C, Mueller F, Aukrust P, Froeland SS. Subnormal serum concentration of 1,25-vitamin D in human immunodeficiency virus infection: correlation with degree of immune deficiency and survival. J Infect Dis 1994; 169:889-893. (Pubitemid 24102128)
11. Gyllensten K, Josephson F, Lidman K, Saaf M. Severe vitamin D deficiency diagnosed after introduction of antiretroviral therapy including efavirenz in a patient living at latitude 59 degrees N. AIDS 2006; 20:1906-1907. (Pubitemid 44358915)
12. Welz T, Childs K, Ibrahim F, Poulton M, Taylor CB, Moniz CF, Post FA. Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase. AIDS 2010; 24:1923-1928.
13. Brown TT, McComsey GA. Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D. Antivir Ther 2010; 15:425-429.
14. Childs KE, Fishman SL, Constable C, Gutierrez JA, Wyatt CM, Dieterich DT, et al. Short communication: inadequate vitamin D exacerbates parathyroid hormone elevations in tenofovir users. AIDS Res Hum Retroviruses 2010; 26:855-859.
15. Rosenvinge MM, Gedela K, Copas AJ, Wilkinson A, Sheehy CA, Bano G, et al. Tenofovir-linked hyperparathyroidism is independently associated with the presence of vitamin D deficiency. J Acquir Immune Defic Syndr 2010; 54:496-499.
16. Cozzolino M, Vidal M, Arcidiacono MV, Tebas P, Yarasheski KE, Dusso AS. HIV-protease inhibitors impair vitamin D bioac-tivation to 1,25- dihydroxyvitamin D. AIDS 2003; 17:513-520. (Pubitemid 36293104)
17. Adams JS, Hewison M. Update in vitamin D. J Clin Endocrinol Metab 2010; 95:471-478.
18. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, Meunier PJ. Prevalence of vitamin D insufficiency in an adult normal population. Osteopor Int 1997; 7:439-443. (Pubitemid 27443069)
19. 3 distribution and status in the body. J Am Coll Nutr 2009; 28:252-256.
20. Tzotzas T, Papadopoulou FG, Tziomalos K, Karras S, Gastaris K, Perros P, Krassas GE. Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance. J Clin Endocrinol Metab 2010; 95:4251-4257.
21. Matsunuma A, Horiuchi N. Leptin attenuates gene expression for renal 25-hydroxyvitamin D3-1a-hydroxylase in mice via the long form of the leptin receptor. Arch Biochem Biophys 2007; 463:118-127. (Pubitemid 46879706)
22. de Zeeuw D, Agarwal R, Amdahl M, Audhya P, Coyne D, Garimella T, et al. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomized controlled trial. Lancet 2010; 376:1543-1551.
23. van Den Bout-van den Beukel CJ, van Den Bos M, Oyen WJ, Hermus AR, Sweep FC, Tack CJ, et al. The effect of cholecalci-ferol supplementation on vitamin D levels and insulin sensitivity is dose related in vitamin D deficient HIV-1-infected patients. HIV Med 2008; 9:771-779.
24. Chun RF, Adams JS, Hewison M. Back to the future: a new look at 'old' vitamin D. J Endocrinol 2008; 198:261-269.
25. Kennel KA, Drake MT, Hurley DL. Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin Proc 2010; 85:752-758.
26. Heinonen OP, Huttunen JK, Albanes D, for the a-Tocopherol b-Carotene Cancer Prevention Study Group. The effect of vitamin E and b-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330:1029-1035. (Pubitemid 24106559)
27. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Effects of a combination of b-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334:1150-1155. (Pubitemid 26137973)
28. El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, Arduino RC, et al; strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4R count-guided interruption of antiretroviral treatment. N Engl J Med 2006; 355:2283-2296. (Pubitemid 44837777)